HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Els J M Weersink Selected Research

Els J M Weersink Research Topics

Disease

16Asthma (Bronchial Asthma)
03/2024 - 06/2011
3Cystic Fibrosis (Mucoviscidosis)
12/2023 - 04/2021
3Chronic Obstructive Pulmonary Disease (COPD)
10/2020 - 06/2009
2COVID-19
06/2023 - 02/2021
1Fibrosis (Cirrhosis)
12/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2023
1Airway Remodeling
10/2023
1Post-Acute COVID-19 Syndrome
06/2023
1Lung Diseases (Lung Disease)
06/2023
1Overweight
01/2023
1Bronchiectasis
01/2023
1Weight Gain
01/2023
1Weight Loss (Weight Reduction)
01/2023
1Inflammation (Inflammations)
01/2022
1Respiratory Hypersensitivity
01/2022
1Disease Progression
01/2022
1Long Term Adverse Effects
06/2011
1Neoplasms (Cancer)
06/2009
1Dyspnea (Shortness of Breath)
06/2009

Drug/Important Bio-Agent (IBA)

6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 06/2011
3reslizumabIBA
01/2023 - 02/2021
3mepolizumabIBA
01/2023 - 10/2020
2Interleukin-5 (Interleukin 5)IBA
01/2023 - 01/2022
2benralizumabIBA
01/2023 - 02/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2dupilumabIBA
07/2021 - 02/2021
1elexacaftorIBA
12/2023
1ivacaftor drug combination tezacaftorIBA
12/2023
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
12/2023
1Oxygen (Dioxygen)IBA
06/2023
1ChloridesIBA
01/2022
1ColforsinIBA
01/2022
1CytokinesIBA
01/2022
1Chloride Channels (Chloride Channel)IBA
04/2021
1lumacaftorIBA
04/2021
1ivacaftorIBA
04/2021
1Omalizumab (Xolair)FDA Link
02/2021
1Prednisone (Sone)FDA LinkGeneric
06/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011
1GoldIBA
06/2009

Therapy/Procedure

6Bronchial Thermoplasty
03/2024 - 01/2019
6Therapeutics
12/2023 - 04/2021
2Electronic Nose
12/2021 - 10/2020
1Immunotherapy
03/2024
1Precision Medicine
06/2023
1Aftercare (After-Treatment)
01/2022
1Biological Therapy
02/2021
1Palliative Care (Palliative Therapy)
06/2009
1Activities of Daily Living (ADL)
06/2009